Caption Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.33M Buy
40,000
+20,000
+100% +$3.69M 0.04% 416
2025
Q4
$3.52M Hold
20,000
0.02% 625
2025
Q3
$2.8M Buy
+20,000
New +$2.7M 0.02% 711
2025
Q1
Sell
-18,000
Closed -$2.75M 1534
2024
Q4
$2.75M Hold
18,000
0.03% 583
2024
Q3
$3.49M Hold
18,000
0.06% 390
2024
Q2
$4.17M Buy
+18,000
New +$3.91M 0.06% 300
2023
Q1
Sell
-174,300
Closed -$48.3M 1110
2022
Q4
$48.3M Sell
174,300
-75,500
-30% -$21.3M 0.75% 16
2022
Q3
$66.7M Buy
249,800
+115,500
+86% +$24.5M 0.92% 11
2022
Q2
$27.4M Buy
134,300
+10,000
+8% +$2.04M 0.38% 47
2022
Q1
$26.2M Sell
124,300
-222,300
-64% -$48.3M 0.31% 62
2021
Q4
$83.2M Buy
346,600
+37,400
+12% +$9.62M 0.93% 4
2021
Q3
$87.5M Buy
309,200
+137,900
+81% +$45.2M 1% 5
2021
Q2
$59.3M Buy
171,300
+121,100
+241% +$36.7M 0.77% 15
2021
Q1
$14M Buy
50,200
+6,200
+14% +$1.67M 0.3% 64
2020
Q4
$10.8M Sell
44,000
-29,100
-40% -$7.51M 0.25% 110
2020
Q3
$20.7M Buy
73,100
+68,800
+1,600% +$19.2M 0.49% 28
2020
Q2
$1.15M Buy
+4,300
New +$1.29M 0.04% 505

Other funds holding BIIB

Caption Management's BIIB Position: Q1 2026 in Review

Caption Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 53,000 shares — an estimated $9.77M sold.

Caption Management first reported a position in BIIB in Q4 2019 and held it in 15 quarters. The position peaked at $63.2M in Q3 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Caption Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 53,000 Biogen shares in Q1 2026, an estimated $9.77M.
  • Caption Management first reported a position in Biogen in Q4 2019 and held it in 15 quarters.
  • Caption Management's Biogen position peaked at $63.2M in Q3 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.